Long Acting Drug Delivery Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Device
1.2.3 Parenteral Injections
1.3 Market by Application
1.3.1 Global Long Acting Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinics
1.3.4 Clinical Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Long Acting Drug Delivery Market Perspective (2017-2028)
2.2 Long Acting Drug Delivery Growth Trends by Region
2.2.1 Long Acting Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Long Acting Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Long Acting Drug Delivery Market Dynamics
2.3.1 Long Acting Drug Delivery Industry Trends
2.3.2 Long Acting Drug Delivery Market Drivers
2.3.3 Long Acting Drug Delivery Market Challenges
2.3.4 Long Acting Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Drug Delivery Players by Revenue
3.1.1 Global Top Long Acting Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Long Acting Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Acting Drug Delivery Revenue
3.4 Global Long Acting Drug Delivery Market Concentration Ratio
3.4.1 Global Long Acting Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Drug Delivery Revenue in 2021
3.5 Long Acting Drug Delivery Key Players Head office and Area Served
3.6 Key Players Long Acting Drug Delivery Product Solution and Service
3.7 Date of Enter into Long Acting Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Drug Delivery Breakdown Data by Type
4.1 Global Long Acting Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Long Acting Drug Delivery Breakdown Data by Application
5.1 Global Long Acting Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Long Acting Drug Delivery Market Size (2017-2028)
6.2 North America Long Acting Drug Delivery Market Size by Country (2017-2022)
6.3 North America Long Acting Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Long Acting Drug Delivery Market Size (2017-2028)
7.2 Europe Long Acting Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Long Acting Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Long Acting Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Long Acting Drug Delivery Market Size (2017-2028)
9.2 Latin America Long Acting Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Long Acting Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Detail
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Long Acting Drug Delivery Introduction
11.1.4 ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022)
11.1.5 ViiV Healthcare Recent Development
11.2 Halozyme Therapeutics
11.2.1 Halozyme Therapeutics Company Detail
11.2.2 Halozyme Therapeutics Business Overview
11.2.3 Halozyme Therapeutics Long Acting Drug Delivery Introduction
11.2.4 Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.2.5 Halozyme Therapeutics Recent Development
11.3 Lubrizol Life Science
11.3.1 Lubrizol Life Science Company Detail
11.3.2 Lubrizol Life Science Business Overview
11.3.3 Lubrizol Life Science Long Acting Drug Delivery Introduction
11.3.4 Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022)
11.3.5 Lubrizol Life Science Recent Development
11.4 Celanese Corporation
11.4.1 Celanese Corporation Company Detail
11.4.2 Celanese Corporation Business Overview
11.4.3 Celanese Corporation Long Acting Drug Delivery Introduction
11.4.4 Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022)
11.4.5 Celanese Corporation Recent Development
11.5 Kashiv BioSciences
11.5.1 Kashiv BioSciences Company Detail
11.5.2 Kashiv BioSciences Business Overview
11.5.3 Kashiv BioSciences Long Acting Drug Delivery Introduction
11.5.4 Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022)
11.5.5 Kashiv BioSciences Recent Development
11.6 4P Therapeutics
11.6.1 4P Therapeutics Company Detail
11.6.2 4P Therapeutics Business Overview
11.6.3 4P Therapeutics Long Acting Drug Delivery Introduction
11.6.4 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.6.5 4P Therapeutics Recent Development
11.7 Ipsen
11.7.1 Ipsen Company Detail
11.7.2 Ipsen Business Overview
11.7.3 Ipsen Long Acting Drug Delivery Introduction
11.7.4 Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022)
11.7.5 Ipsen Recent Development
11.8 Midatech Pharma
11.8.1 Midatech Pharma Company Detail
11.8.2 Midatech Pharma Business Overview
11.8.3 Midatech Pharma Long Acting Drug Delivery Introduction
11.8.4 Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022)
11.8.5 Midatech Pharma Recent Development
11.9 Re-Vana Therapeutics
11.9.1 Re-Vana Therapeutics Company Detail
11.9.2 Re-Vana Therapeutics Business Overview
11.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Introduction
11.9.4 Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.9.5 Re-Vana Therapeutics Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Detail
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Long Acting Drug Delivery Introduction
11.10.4 Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022)
11.10.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Long Acting Drug Delivery Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Device
Table 3. Key Players of Parenteral Injections
Table 4. Global Long Acting Drug Delivery Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Long Acting Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Long Acting Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Long Acting Drug Delivery Market Share by Region (2017-2022)
Table 8. Global Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Long Acting Drug Delivery Market Share by Region (2023-2028)
Table 10. Long Acting Drug Delivery Market Trends
Table 11. Long Acting Drug Delivery Market Drivers
Table 12. Long Acting Drug Delivery Market Challenges
Table 13. Long Acting Drug Delivery Market Restraints
Table 14. Global Long Acting Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Long Acting Drug Delivery Market Share by Players (2017-2022)
Table 16. Global Top Long Acting Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2021)
Table 17. Ranking of Global Top Long Acting Drug Delivery Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Long Acting Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Long Acting Drug Delivery Product Solution and Service
Table 21. Date of Enter into Long Acting Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long Acting Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Long Acting Drug Delivery Revenue Market Share by Type (2017-2022)
Table 25. Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Long Acting Drug Delivery Revenue Market Share by Type (2023-2028)
Table 27. Global Long Acting Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Long Acting Drug Delivery Revenue Market Share by Application (2017-2022)
Table 29. Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Long Acting Drug Delivery Revenue Market Share by Application (2023-2028)
Table 31. North America Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Long Acting Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Long Acting Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 41. ViiV Healthcare Company Detail
Table 42. ViiV Healthcare Business Overview
Table 43. ViiV Healthcare Long Acting Drug Delivery Product
Table 44. ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 45. ViiV Healthcare Recent Development
Table 46. Halozyme Therapeutics Company Detail
Table 47. Halozyme Therapeutics Business Overview
Table 48. Halozyme Therapeutics Long Acting Drug Delivery Product
Table 49. Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 50. Halozyme Therapeutics Recent Development
Table 51. Lubrizol Life Science Company Detail
Table 52. Lubrizol Life Science Business Overview
Table 53. Lubrizol Life Science Long Acting Drug Delivery Product
Table 54. Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 55. Lubrizol Life Science Recent Development
Table 56. Celanese Corporation Company Detail
Table 57. Celanese Corporation Business Overview
Table 58. Celanese Corporation Long Acting Drug Delivery Product
Table 59. Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 60. Celanese Corporation Recent Development
Table 61. Kashiv BioSciences Company Detail
Table 62. Kashiv BioSciences Business Overview
Table 63. Kashiv BioSciences Long Acting Drug Delivery Product
Table 64. Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 65. Kashiv BioSciences Recent Development
Table 66. 4P Therapeutics Company Detail
Table 67. 4P Therapeutics Business Overview
Table 68. 4P Therapeutics Long Acting Drug Delivery Product
Table 69. 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 70. 4P Therapeutics Recent Development
Table 71. Ipsen Company Detail
Table 72. Ipsen Business Overview
Table 73. Ipsen Long Acting Drug Delivery Product
Table 74. Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 75. Ipsen Recent Development
Table 76. Midatech Pharma Company Detail
Table 77. Midatech Pharma Business Overview
Table 78. Midatech Pharma Long Acting Drug Delivery Product
Table 79. Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 80. Midatech Pharma Recent Development
Table 81. Re-Vana Therapeutics Company Detail
Table 82. Re-Vana Therapeutics Business Overview
Table 83. Re-Vana Therapeutics Long Acting Drug Delivery Product
Table 84. Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 85. Re-Vana Therapeutics Recent Development
Table 86. Creative Biolabs Company Detail
Table 87. Creative Biolabs Business Overview
Table 88. Creative Biolabs Long Acting Drug Delivery Product
Table 89. Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)
Table 90. Creative Biolabs Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long Acting Drug Delivery Market Share by Type: 2021 VS 2028
Figure 2. Device Features
Figure 3. Parenteral Injections Features
Figure 4. Global Long Acting Drug Delivery Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Clinical Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Long Acting Drug Delivery Report Years Considered
Figure 10. Global Long Acting Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Long Acting Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Long Acting Drug Delivery Market Share by Region: 2021 VS 2028
Figure 13. Global Long Acting Drug Delivery Market Share by Players in 2021
Figure 14. Global Top Long Acting Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Long Acting Drug Delivery Revenue in 2021
Figure 16. North America Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Long Acting Drug Delivery Market Share by Country (2017-2028)
Figure 18. United States Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Long Acting Drug Delivery Market Share by Country (2017-2028)
Figure 22. Germany Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Long Acting Drug Delivery Market Share by Region (2017-2028)
Figure 30. China Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Long Acting Drug Delivery Market Share by Country (2017-2028)
Figure 38. Mexico Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Long Acting Drug Delivery Market Share by Country (2017-2028)
Figure 42. Turkey Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. ViiV Healthcare Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 45. Halozyme Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 46. Lubrizol Life Science Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 47. Celanese Corporation Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 48. Kashiv BioSciences Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 49. 4P Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 50. Ipsen Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 51. Midatech Pharma Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 52. Re-Vana Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 53. Creative Biolabs Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed